Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
Background: Increased plasma plasminogen activator inhibitor-1 (PAI-1) activity and decreased tissue plasminogen activator (tPA) activity could be considered a true component of the metabolic syndrome (MetS) associated with an increased risk of developing cardiovascular diseases (CVD) and fibrinolyt...
Saved in:
Main Authors: | Al-Hamodi, Z., Ismail, I.S., Saif-Ali, R., Ahmed, K.A., Muniandy, S. |
---|---|
Format: | Article |
Language: | English |
Published: |
2011
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/7212/1/Al-Hamodi-2011-Association_of_plasm.pdf http://eprints.um.edu.my/7212/ http://link.springer.com/article/10.1186%2F1475-2840-10-23?LI=true |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of plasminogen activator inhibitor-1 and tissue plasminogen activator polymorphisms on susceptibility to type 2 diabetes in malaysian subjects
by: Al-Hamodi, Z., et al.
Published: (2012) -
Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects
by: Al-Hamodi, Z.H., et al.
Published: (2012) -
The association between serum and tear plasminogen activator inhibitor-1 and tissue plasminogen activator in patients with diabetic retinopathy / Nurbadriah Jasmiad
by: Jasmiad, Nurbadriah
Published: (2021) -
QSAR modelling to predict structural features of certain sulfonamide as Urokinase-type Plasminogen Activator inhibitors
by: Jawarkar, Rahul D, et al.
Published: (2024) -
Intracameral recombinant tissue plasminogen activator (rtPA) as the primary treatment for secondary pupillary block
by: Siti Noor Atikah AR,, et al.
Published: (2022)